 Onconova Therapeutics, Inc. NASDAQ:ONTX Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Bruce Mackle - Investor Relations, LifeSci Advisors Dr. Steve Fruchtman - President Chief Executive Officer Dr. Mark Gelder - Chief Medical Officer Mark Guerin - Chief Operating Officer Chief Financial Officer Conference Call Participants Charles Zhu - Guggenheim Securities Ahu Demir - Ladenburg Thalmann Robert LeBoyer - Noble Capital Operator Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Third Quarter 2022 Financial Results and Business Update Conference Call. 